Show simple item record

dc.contributor.authorHanden, Benjamin
dc.contributor.authorClare, Isabel
dc.contributor.authorLaymon, Charles
dc.contributor.authorPetersen, Melissa
dc.contributor.authorZaman, Shahid
dc.contributor.authorO'Bryant, Sid
dc.contributor.authorMinhas, Davneet
dc.contributor.authorTudorascu, Dana
dc.contributor.authorBrown, Stephanie
dc.contributor.authorChristian, Bradley
dc.date.accessioned2021-11-10T00:30:11Z
dc.date.available2021-11-10T00:30:11Z
dc.date.issued2021-08-23
dc.identifier.issn2076-3425
dc.identifier.urihttps://www.repository.cam.ac.uk/handle/1810/330508
dc.description.abstractBACKGROUND: Acute regression has been reported in some individuals with Down syndrome (DS), typically occurring between the teenage years and mid to late 20s. Characterized by sudden, and often unexplained, reductions in language skills, functional living skills and reduced psychomotor activity, some individuals have been incorrectly diagnosed with Alzheimer's disease (AD). METHODS: This paper compares five individuals with DS who previously experienced acute regression with a matched group of 15 unaffected individuals with DS using a set of AD biomarkers. RESULTS: While the sample was too small to conduct statistical analyses, findings suggest there are possible meaningful differences between the groups on proteomics biomarkers (e.g., NfL, total tau). Hippocampal, caudate and putamen volumes were slightly larger in the regression group, the opposite of what was hypothesized. A slightly lower amyloid load was found on the PET scans for the regression group, but no differences were noted on tau PET. CONCLUSIONS: Some proteomics biomarker findings suggest that individuals with DS who experience acute regression may be at increased risk for AD at an earlier age in comparison to unaffected adults with DS. However, due to the age of the group (mean 38 years), it may be too early to observe meaningful group differences on image-based biomarkers.
dc.format.mediumElectronic
dc.languageeng
dc.publisherMDPI AG
dc.rightsAttribution 4.0 International
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/
dc.titleAcute Regression in Down Syndrome.
dc.typeArticle
prism.issueIdentifier8
prism.publicationDate2021
prism.publicationNameBrain Sci
prism.volume11
dc.identifier.doi10.17863/CAM.77951
dcterms.dateAccepted2021-08-13
rioxxterms.versionofrecord10.3390/brainsci11081109
rioxxterms.versionVoR
rioxxterms.licenseref.urihttp://www.rioxx.net/licenses/all-rights-reserved
rioxxterms.licenseref.startdate2021-08-23
dc.contributor.orcidClare, Isabel [0000-0002-5385-008X]
dc.contributor.orcidZaman, Shahid [0000-0003-1639-6014]
dc.contributor.orcidBrown, Stephanie [0000-0002-8747-7770]
dc.identifier.eissn2076-3425
rioxxterms.typeJournal Article/Review
cam.issuedOnline2021-08-23


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record

Attribution 4.0 International
Except where otherwise noted, this item's licence is described as Attribution 4.0 International